Along with Nutley-based Eisai, several other New Jersey-based giants in the space have conducted layoffs over the past few ...
A seven month long investigation led to the arrest of a Greenwood man yesterday. According to the Johnson County Sheriff's ...
Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...
Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...
FDA reform needs to be underpinned by strategy, not ‘indiscriminate’ cuts The Trump administration could save the lives of ...
As we observe Rare Disease Day today, let us take a look at seven drugs poised to be approved to address rare diseases in ...
Newly appointed “pardon czar” Alice Marie Johnson’s role has been met with cautious optimism from decarceration advocates, given President Donald Trump’s unpredictable stance on criminal justice ...
Eisai plans to lay off 121 employees in the U.S. A former deputy director of China's drug agency is under investigation by ...
After two years in the shadows, health stocks are back as a haven for investors navigating economic uncertainty.
Zevra has sold its US Food and Drug Administration (FDA) priority review voucher (PRV) for $150m to an undisclosed party. The ...
Givinostat should be available to people with Duchenne muscular dystrophy through a type of compassionate use scheme.
A Johnson & Johnson unit working to resolve massive cancer litigation in bankruptcy court was accused by a former head of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results